PMV Pharmaceuticals (PMVP) Metrics: History & Chart

PMV Pharmaceuticals, Inc.(PMVP)

Biotechnology · Princeton, NJ

$1.61-0.17 (-9.40%)

Delayed quote: Oct 6, 2026, 3:45 PM EDT

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.

Princeton, NJ

54 employees

www.pmvpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David H. Mack

View full financials

Third-Party DCF Estimate (FMP)	$0.65
Price Gap vs Third-Party Estimate	-61.36%

7D Total Return	+30.88%
30D Total Return	+37.98%
YTD Total Return	+42.40%
1Y Total Return	+23.61%
3Y Total Return	-71.25%
5Y Total Return	-94.07%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+42.40%
2025	-17.22%
2024	-51.29%
2023	-64.37%
2022	-62.34%
2021	-62.45%
2020

CAGR TTM	+23.49%
CAGR 3Y	-33.99%
CAGR 5Y	-43.17%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

PMVP Valuation Metrics

PMVP Stock Price Metrics

PMVP Dividend Metrics

PMVP Growth Rate Metrics

PMVP Discounted Cash Flow Metrics

PMVP Returns By Period

PMVP Yearly Returns

PMVP Average Annual Returns By Period (CAGR)

PMVP Revenue Metrics

PMVP PE Ratio Metrics

PMVP PS Ratio Metrics

PMVP PB Ratio Metrics

PMVP Price to Free Cash Flow Ratio Metrics

PMVP Debt to Equity Ratio Metrics

PMVP PEG Ratio Metrics

PMVP FCF Yield

PMVP Earnings Yield

PMVP EBITDA Yield

PMVP OCF Yield

PMVP EV/EBIT Ratio Metrics

PMVP EV/EBITDA Ratio Metrics

PMVP EV/Assets Ratio Metrics

PMVP EV/Sales Ratio Metrics

PMVP Current Ratio Metrics

PMVP Quick Ratio Metrics

PMVP ROIC Metrics

PMVP Return on Assets Metrics

PMVP Return on Equity Metrics

PMVP Net Profit Margin Metrics

PMVP Gross Profit Margin Metrics

PMVP Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	1.33
PB Ratio Avg TTM	0.68
PB Ratio Avg 3Y	0.47
Current VS TTM Avg	+96.93%
Current VS 3Y Avg	+182.32%
Current VS 5Y Avg	+26.82%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.03
Current VS TTM Avg	-48.24%
Current VS 3Y Avg	-90.23%
Current VS 5Y Avg	-91.58%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.01
Ev/Assets Ratio Avg TTM	0.26
Ev/Assets Ratio Avg 3Y	0.21
Current VS TTM Avg	+295.15%
Current VS 3Y Avg	+385.94%
Current VS 5Y Avg	+47.30%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	7.70
Current Ratio Avg TTM	10.45
Current Ratio Avg 3Y	13.98
Current VS TTM Avg	-26.25%
Current VS 3Y Avg	-44.91%
Current VS 5Y Avg	-57.21%

Quick Ratio	7.70
Quick Ratio Avg TTM	10.45
Quick Ratio Avg 3Y	13.98
Current VS TTM Avg	-26.25%
Current VS 3Y Avg	-44.91%
Current VS 5Y Avg	-57.21%

ROIC	(111.42%)
ROIC Avg 3Y	(56.97%)
ROIC Avg 5Y	(40.52%)
Current VS 3Y Avg	-95.58%
Current VS 5Y Avg	-174.94%
Current VS 10Y Avg	-253.41%

ROA	(91.66%)
ROA Avg TTM	(17.16%)
ROA Avg 3Y	(11.03%)
Current VS TTM Avg	-434.14%
Current VS 3Y Avg	-730.79%
Current VS 5Y Avg	-993.79%

ROE	(105.20%)
ROE Avg TTM	(78.88%)
ROE Avg 3Y	(49.25%)
Current VS TTM Avg	-33.38%
Current VS 3Y Avg	-113.59%
Current VS 5Y Avg	-267.05%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	2.72%
Tax Rate Avg 3Y	6.06%
Tax Rate Avg 5Y	4.03%
Current VS 3Y Avg	-55.13%
Current VS 5Y Avg	-32.53%
Current VS 10Y Avg	-9.86%